GNH USA

Europe — EMA

Montelukast Bluefish Pharma

GNH USA supplies Montelukast Bluefish Pharma (Montelukast), a receptor antagonist for asthma and allergic rhinitis. Request a quote, global supply.

Montelukast

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Montelukast Bluefish Pharma, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It is indicated for maintenance therapy of asthma, relief of allergic rhinitis, and prevention of exercise‑induced bronchoconstriction in both adults and children.

GNH USA supplies Montelukast Bluefish Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable logistics and responsive technical support.

What is Montelukast used for?

Montelukast acts on leukotriene pathways to manage several respiratory and allergic conditions.

Asthma: Improves long‑term control and reduces frequency of asthma attacks. Allergic rhinitis: Alleviates nasal congestion, sneezing and itching associated with seasonal allergies. Exercise‑induced bronchoconstriction: Prevents airway narrowing triggered by physical activity.

What are the side effects of Montelukast?

Montelukast may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Headache: mild to moderate head pain. - Abdominal pain: discomfort or cramps in the stomach area. - Nausea: feeling of queasiness. - Cough: transient irritation of the throat.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, tongue or throat. - Mood changes: depression, anxiety, or suicidal thoughts. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

What precautions apply to Montelukast?

Montelukast should be used with consideration of specific patient factors and potential risks.

Pregnancy: safety not established; consult a healthcare provider. Breastfeeding: unknown safety; weigh benefits against risks. Renal impairment: use with caution and monitor renal function. Concomitant phenobarbital: may reduce montelukast effectiveness. Neuropsychiatric monitoring: observe for mood changes or suicidal thoughts. Store below 25°C: keep in the original packaging, protect from moisture and light.

What does Montelukast interact with?

Montelukast can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma concentrations. - Phenobarbital: may lower montelukast levels, reducing effectiveness. - Carbamazepine: may decrease montelukast exposure.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect; monitor INR. - Theophylline: possible additive bronchodilator effect; observe clinical response.

Frequently asked questions

What conditions is Montelukast Bluefish Pharma used for?+
Montelukast Bluefish Pharma is prescribed for the long‑term management of asthma, for relief of symptoms associated with allergic rhinitis, and to prevent exercise‑induced bronchoconstriction. These indications reflect its role as a leukotriene receptor antagonist that reduces airway inflammation and constriction.
How does Montelukast work in the body?+
Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from binding. By inhibiting this pathway, it reduces bronchoconstriction, mucus production, vascular leakage, and inflammatory cell recruitment, leading to improved airway patency and decreased allergic inflammation.
What is the usual dose of Montelukast Bluefish Pharma?+
The appropriate dose of Montelukast Bluefish Pharma is determined by the prescribing healthcare professional based on the patient’s age, condition, and clinical response. Dosage instructions are individualized and should be followed exactly as written on the prescription label.
Is Montelukast safe to use during pregnancy or while breastfeeding?+
Safety data for Montelukast during pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and decisions should be made in consultation with a qualified healthcare provider.
How do I order Montelukast Bluefish Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Montelukast compare with other asthma treatments?+
Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑sensitive asthma or those who need additional control of allergic symptoms, though it may be less potent for acute bronchospasm relief.
What are the recommended storage conditions for Montelukast Bluefish Pharma?+
Montelukast Bluefish Pharma should be stored below 25 °C in its original packaging, protected from moisture and direct light. Keeping the product in a dry, temperature‑controlled environment helps maintain its stability and potency throughout its shelf life.
How is Montelukast Bluefish Pharma administered?+
The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Consistency in the time of day helps maintain steady drug levels, and patients should swallow the tablet whole with water unless otherwise instructed.
What are the most serious risks associated with Montelukast?+
Serious adverse events, though rare, include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, and neuropsychiatric effects like depression, anxiety, or suicidal thoughts. Any sudden swelling, rash, or mood changes should prompt immediate medical evaluation.
Who should not take Montelukast Bluefish Pharma?+
Montelukast is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients. Patients with a history of severe allergic reactions to leukotriene modifiers should avoid its use, and clinicians should assess suitability on a case‑by‑case basis.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
Bluefish Pharmaceuticals Ab
Origin
EU

Related products

MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA